Ansell (ANN) AI Stock Analysis

• Market Cap: $4.93B
• Dividend Yield: 2.31%
• Average Volume (3M): 411.87K
• Price to Earnings (P/E): 31.4
• Beta (1Y): 1.15
• Revenue Growth: 25.19%
• EPS Growth: 18.82%
• Country: AU
• Employees: 15,000
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 1.05
• Shares Outstanding: 145,944,890
• 10 Day Avg. Volume: 331,215
• 30 Day Avg. Volume: 411,865
• PEG Ratio: 1.53
• Price to Book (P/B): 1.47
• Price to Sales (P/S): 1.45
• P/FCF Ratio: 17.03
• Enterprise Value/Market Cap: 1.08
• Enterprise Value/Revenue: 2.87
• Enterprise Value/Gross Profit: 7.35
• Enterprise Value/Ebitda: 18.26
• 1Y Price Target: $36.02
• Price Target Upside: 6.14% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 8

• Rating: 70 Outperform
• Price Target: AU$33.00 ▼(-2.77% Downside)

Ansell's overall stock score reflects strong financial performance and positive earnings call highlights. The bullish technical indicators support the stock's upward trend, although the high P/E ratio suggests it may be overvalued. The company's strategic initiatives and growth prospects are promising, but challenges like tariff impacts and cash flow reduction need to be addressed.

Ansell Business Overview & Revenue Model

Company Description

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia. P. D. Holdings Pty. Ltd. operates as a current subsidiary of Ansell Limited.

How the Company Makes Money

Ansell generates revenue through the sale of its diverse product portfolio, primarily focusing on personal protective equipment and healthcare solutions. The company's revenue streams are divided into two main business segments: Industrial and Healthcare. The Industrial segment caters to industries requiring hand and body protection, providing products like mechanical gloves, chemical resistant gloves, and disposable gloves. The Healthcare segment offers solutions primarily to healthcare professionals and facilities, including surgical gloves, examination gloves, and infection prevention products. Significant partnerships with distributors, healthcare institutions, and industrial clients enhance Ansell's market reach and contribute to its earnings. The company benefits from a strong global distribution network and a focus on innovation and quality, which helps maintain its competitive edge and profitability.

Ansell Financial Statement Overview

Summary

Ansell demonstrates solid financial performance with strong revenue growth and stable margins. The balance sheet is healthy with moderate leverage and a strong equity base. However, the decline in free cash flow growth is a concern that needs addressing.

Income Statement

Ansell's income statement shows a solid revenue growth rate of 8.05% in the latest year, reversing the previous year's decline. The gross profit margin improved to 41.18%, indicating better cost management. However, the net profit margin is relatively low at 5.07%, suggesting room for improvement in profitability. The EBIT and EBITDA margins are moderate, reflecting stable operational efficiency.

Balance Sheet

The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.41, indicating moderate leverage. The return on equity is 5.17%, which is modest and suggests potential for better utilization of equity. The equity ratio stands at 59.09%, highlighting a strong equity base relative to total assets.

Cash Flow

Cash flow analysis reveals a decline in free cash flow growth by 22.69%, which is a concern. The operating cash flow to net income ratio is 2.36, indicating strong cash generation relative to net income. However, the free cash flow to net income ratio of 1.67 suggests that free cash flow is not as robust as it could be.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.85B	2.00B	1.62B	1.63B	1.85B	2.04B
Gross Profit	725.00M	825.00M	624.80M	604.22M	625.19M	807.21M
EBITDA	291.80M	260.20M	202.30M	275.20M	291.90M	401.60M
Net Income	112.10M	101.60M	76.50M	148.30M	158.70M	246.70M
Balance Sheet
Total Assets	3.27B	3.32B	3.24B	2.52B	2.51B	2.74B
Cash, Cash Equivalents and Short-Term Investments	268.90M	238.30M	912.30M	159.03M	206.18M	240.21M
Total Debt	825.70M	805.60M	857.20M	493.15M	485.74M	515.53M
Total Liabilities	1.35B	1.34B	1.33B	913.07M	949.48M	1.17B
Stockholders Equity	1.91B	1.96B	1.89B	1.60B	1.54B	1.55B
Cash Flow
Free Cash Flow	219.90M	170.00M	208.60M	95.37M	127.71M	72.17M
Operating Cash Flow	272.90M	239.30M	272.30M	161.72M	191.71M	155.40M
Investing Cash Flow	-688.70M	-703.30M	-63.40M	-74.54M	-67.51M	-85.25M
Financing Cash Flow	518.10M	-216.00M	540.80M	-130.82M	-148.76M	-250.72M

Ansell Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 33.94
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ANN, the sentiment is Positive. The current price of 33.94 is below the 20-day moving average (MA) of 34.05, above the 50-day MA of 31.91, and above the 200-day MA of 32.13, indicating a neutral trend. The MACD of 0.47 indicates Positive momentum. The RSI at 59.47 is Neutral, neither overbought nor oversold. The STOCH value of 24.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ANN.

Ansell Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RMD	71 Outperform	60.72B	28.07	23.47%	0.81%	11.26%	39.47%
ANN	70 Outperform	$4.93B	31.43	5.27%	2.31%	25.19%	18.82%
RHC	61 Neutral	7.57B	1,113.85	0.00%	2.43%	6.82%	-99.27%
REG	57 Neutral	2.78B	56.74	-292.70%	1.76%	14.61%	0.00%
TRJ	55 Neutral	114.79M	-25.67	-4.22%	―	7.38%	82.39%
CU6	53 Neutral	1.39B	-18.61	0.00%	―	0.00%	-29.93%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Ansell Corporate Events

Ansell Limited Announces New Director Appointment

Ansell Limited has announced the appointment of Randy Stone as a director effective August 1, 2025. The initial director’s interest notice reveals that Randy Stone currently holds no securities or interests in the company, indicating a fresh start in his role. This appointment is a strategic move for Ansell, potentially impacting its governance and strategic direction.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.00 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Issues Restricted Stock Units Under Employee Incentive Scheme

Ansell Limited announced the issuance of 33,108 restricted stock units under an employee incentive scheme. These securities are unquoted and subject to transfer restrictions until the restriction period ends, reflecting the company’s ongoing commitment to employee engagement and retention strategies.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$40.00 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Announces Board Changes Amidst Succession Plan

Ansell Limited announced changes to its Board of Directors as part of its ongoing succession and renewal plan. Non-Executive Director Morten Falkenberg will retire at the end of May 2025, and Randy Stone will join as an independent Non-Executive Director in August 2025. Stone brings extensive international experience and expertise in industries closely aligned with Ansell’s focus, which is expected to enhance the Board’s capabilities and support the company’s strategic goals.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$40.00 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.